Revisión de la investigación sobre los receptores tipo TollMay 6, 2026Una nueva revisión sobre los receptores tipo Toll (TLR) resume sistemáticamente cuarenta años de…View Resource Still's Disease and FeverMay 6, 2026Know-it-now: Still’s disease required diagnostic triad is non-negotiable: 1) quotidian daily spiking fevers (>39°C),…View Resource Follow the Money (4.23.2026)April 24, 2026El Dr. Jack Cush sigue el dinero y todas las noticias relevantes de la…View Resource Still's Disease UpdateApril 15, 2026Arthritis Research & Therapy ha publicado una revisión general de la enfermedad de Still,…View Resource Top Four and More (4.10.2026)April 10, 2026Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week –…View Resource Moral Distress (3.27.2026)March 27, 2026Dr. Jack Cush reviews the journal reports and news from RheumNow.com. This week we…View Resource Rheumatology Pitfalls (3.20.2026)March 20, 2026Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past…View Resource UBER Rheumatology Ride (3.6.2026)March 6, 2026Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com…View Resource ANA Pollution (2.06.2026)February 6, 2026Dr. Jack Cush reviews the news, journal articles and regulatory news from this past…View Resource The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource 12345…6789101112131415→
Still's Disease and FeverMay 6, 2026Know-it-now: Still’s disease required diagnostic triad is non-negotiable: 1) quotidian daily spiking fevers (>39°C),…View Resource Follow the Money (4.23.2026)April 24, 2026El Dr. Jack Cush sigue el dinero y todas las noticias relevantes de la…View Resource Still's Disease UpdateApril 15, 2026Arthritis Research & Therapy ha publicado una revisión general de la enfermedad de Still,…View Resource Top Four and More (4.10.2026)April 10, 2026Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week –…View Resource Moral Distress (3.27.2026)March 27, 2026Dr. Jack Cush reviews the journal reports and news from RheumNow.com. This week we…View Resource Rheumatology Pitfalls (3.20.2026)March 20, 2026Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past…View Resource UBER Rheumatology Ride (3.6.2026)March 6, 2026Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com…View Resource ANA Pollution (2.06.2026)February 6, 2026Dr. Jack Cush reviews the news, journal articles and regulatory news from this past…View Resource The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource 12345…6789101112131415→
Follow the Money (4.23.2026)April 24, 2026El Dr. Jack Cush sigue el dinero y todas las noticias relevantes de la…View Resource Still's Disease UpdateApril 15, 2026Arthritis Research & Therapy ha publicado una revisión general de la enfermedad de Still,…View Resource Top Four and More (4.10.2026)April 10, 2026Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week –…View Resource Moral Distress (3.27.2026)March 27, 2026Dr. Jack Cush reviews the journal reports and news from RheumNow.com. This week we…View Resource Rheumatology Pitfalls (3.20.2026)March 20, 2026Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past…View Resource UBER Rheumatology Ride (3.6.2026)March 6, 2026Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com…View Resource ANA Pollution (2.06.2026)February 6, 2026Dr. Jack Cush reviews the news, journal articles and regulatory news from this past…View Resource The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource 12345…6789101112131415→
Still's Disease UpdateApril 15, 2026Arthritis Research & Therapy ha publicado una revisión general de la enfermedad de Still,…View Resource Top Four and More (4.10.2026)April 10, 2026Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week –…View Resource Moral Distress (3.27.2026)March 27, 2026Dr. Jack Cush reviews the journal reports and news from RheumNow.com. This week we…View Resource Rheumatology Pitfalls (3.20.2026)March 20, 2026Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past…View Resource UBER Rheumatology Ride (3.6.2026)March 6, 2026Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com…View Resource ANA Pollution (2.06.2026)February 6, 2026Dr. Jack Cush reviews the news, journal articles and regulatory news from this past…View Resource The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource 12345…6789101112131415→
Top Four and More (4.10.2026)April 10, 2026Dr. Jack Cush reviews the news and journal reports from RheumNow.com this week –…View Resource Moral Distress (3.27.2026)March 27, 2026Dr. Jack Cush reviews the journal reports and news from RheumNow.com. This week we…View Resource Rheumatology Pitfalls (3.20.2026)March 20, 2026Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past…View Resource UBER Rheumatology Ride (3.6.2026)March 6, 2026Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com…View Resource ANA Pollution (2.06.2026)February 6, 2026Dr. Jack Cush reviews the news, journal articles and regulatory news from this past…View Resource The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource 12345…6789101112131415→
Moral Distress (3.27.2026)March 27, 2026Dr. Jack Cush reviews the journal reports and news from RheumNow.com. This week we…View Resource Rheumatology Pitfalls (3.20.2026)March 20, 2026Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past…View Resource UBER Rheumatology Ride (3.6.2026)March 6, 2026Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com…View Resource ANA Pollution (2.06.2026)February 6, 2026Dr. Jack Cush reviews the news, journal articles and regulatory news from this past…View Resource The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource 12345…6789101112131415→
Rheumatology Pitfalls (3.20.2026)March 20, 2026Dr. Jack Cush reviews the regulatory actions, news and journal reports from this past…View Resource UBER Rheumatology Ride (3.6.2026)March 6, 2026Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com…View Resource ANA Pollution (2.06.2026)February 6, 2026Dr. Jack Cush reviews the news, journal articles and regulatory news from this past…View Resource The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource 12345…6789101112131415→
UBER Rheumatology Ride (3.6.2026)March 6, 2026Dr. Jack Cush reviews the news and journal reports from this week on RheumNow.com…View Resource ANA Pollution (2.06.2026)February 6, 2026Dr. Jack Cush reviews the news, journal articles and regulatory news from this past…View Resource The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource 12345…6789101112131415→
ANA Pollution (2.06.2026)February 6, 2026Dr. Jack Cush reviews the news, journal articles and regulatory news from this past…View Resource The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource 12345…6789101112131415→
The 2025 Rheumatology Year in ReviewJanuary 16, 2026The year 2025 presented numerous advances in rheumatology and related inflammatory and autoimmune disorders…View Resource